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Introduction 
 
Klebsiella pneumoniae is an opportunistic 
pathogen that causes a significant proportion of 
community and hospital acquired infections 
including urinary tract, pneumonia, septicemia 
and soft tissue infections (1). Extended-
spectrum ß-lactam antibiotics have been widely 
used for treatment of serious Gram-negative 
infections since the 1980s. However, bacterial 
resistance has emerged quickly due to the 
production of ESBLs (2-6). These enzymes are 
capable of hydrolyzing extended spectrum β-
lactam antibiotics such as ceftazidime, 
ceftriaxone, cefotaxime and aztreonam. ESBLs 
are derived from genes for the narrower-
spectrum ß-lactamases (TEM-1, TEM-2 or 
SHV-1) by mutations that alter the amino acid 
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configuration around the enzyme active site (4, 
5). They are typically encoded by plasmids that 
can be exchanged between bacterial species (7, 
8). It is also reported that the predominant types 
of ESBLs in K. pneumoniae are SHV type 
followed by TEM and CTX-M (2, 4, 9, 10). 
The prevalence of ESBL producing K. pneumo-
niae varies around the world and has been re-
ported to be around 1-5% in European countries, 
7.5% in North America, 13.3% in Europe, 
22.4% in Asia Pacific Rim, 44% in Latin Amer-
ica, 48.5% in Turkey, 51% in China, 71.4% in 
Mexico and 72% in India (4, 11-13). The preva-
lence of ESBL producing K. pneumoniae in Iran 
is reported to range from 19.6 to 75% with SHV 
as the dominant type (14-18). We studied ESBL 
production in the urinary isolates of Klebsiella 
pneumoniae in relation to the presence of SHV, 
TEM and CTX-M -lactamase genes among the 
isolates. 
 
Materials and methods 
 
Fifty one urinary isolates of K. pneumoniae 
were chosen from a collection of urinary isolates 
between March and August 2008 from two hos-
pitals in Tehran (Taleghani and Imam Hussein). 
The isolates were tested for antimicrobial sus-
ceptibility by the disc diffusion method accord-
ing to the NCCLS guidelines (19). The antibi-
otic discs were obtained from Padtan Teb (Te-
hran, Iran) and the following antibiotics were 
used: amoxicillin (30 g), amikacin (30g), cef-
tazidime (30g), cefotaxime (30g), cefteriaxon 
(30g), ceftizoxime (30g), gentamicin (10g), 
ciprofloxacin (10g), and nitrofurantoin (300g). 
Minimum inhibitory concentrations were also 
measured for 5 antibiotics using the broth mi-
crodilution method and the NCCLS guidelines 
(20). 
The double disc synergy test (DDST) was used 
to detect ESBL production (21). Briefly, the or-
ganisms were swabbed on to Mueller-Hinton 
agar plates (as performed for disc diffusion), an 
amoxiclav disc (20 + 10 g) was placed in the 
center of the plate and ceftizoxime (30g), cefo-
taxime (30g), cefteriaxon (30g) discs were 
placed 15 mm away from the central disc. The 
plates were incubated at 37 oC for up to 24 h. An 
increase of > 5 mm inhibition zone for antibiot-
ics around the amoxyclav disc compared to the 
cephalosporin discs alone was considered ESBL 
production. ESBL production was further con-
firmed by the phenotypic confirmatory test 
(PCT) using ceftazidime and ceftazi-
dime/clavlanic acid (22). 
Genomic DNA was prepared from overnight 
cultures grown on Lauria-Bertani broth [LB] 
(Hi-Media, Mumbai, India) by inoculating a sin-
gle colony into 100 l of double distilled water 
and boiling for 10 min. An equal volume of 
chloroform: isoamyl alcohol (24:1 v/v) was 
added, mixed by end over end rotation and the 
mixture was centrifuged at 8000 x g for 15 min. 
The upper layer was then used in the PCR reac-
tion mixtures (21). 
PCR amplification was carried out with specific 
primers for blaSHV (forward: 5’-TGG TTA TGC 
GTT ATA TTC GCC-3’, and reverse: 5’-GGT 
TAG CGT TGC CAG TGCT-3’) amplifying an 
800 bp fragment (Fazapajouh, Tehran), blaTEM 
(forward: 5’-ATA AAA TTC TTG AAG ACG 
AA-3’, reverse: 5’-GAC AGT TAC CAA TGC 
TTA ATC-3’) amplifying an 850 bp fragment 
and blaCTX-M (forward; 5’-TGG TTA AAA ATC 
ACT ACT GCG-3’, reverse: 5’-ATT ACA AAC 
CGT CGG TGA C-3’) amplifying an 891 bp 
product (Takapou Zist, Tehran) (22-24). PCR 
was carried out in 25 µl volume reaction mix-
tures containing 10 pM of each primer, 200 µM 
dNTP, 1.5 mM MgCl2, 1.5 µl of crude template 
DNA and 1 U Taq polymerase in the reaction 
buffer provided by the manufacturer (CinnaGen, 
Tehran, Iran). The following thermocycler pro-
gram was carried out for PCR experiments: 4 
min denaturation at 94 oC followed by 32 cycles 
of 1 min at 94 oC, 1 min at the annealing tem-
perature (55 oC for blaSHV and blaCTX-M and 58 
oC for blaTEM) and 1 min at 72 oC with a final 
extension period of 10 min at 72 oC. 
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Results 
 
The antibiotic susceptibility profile measured by 
disc diffusion is shown in figure 1.  As observed 
the highest rate of resistance was found for 
amoxicillin (96.08 %) and the lowest for gen-
tamicin and ciprofloxacin (29.42 %). Among the 
broad spectrum -lactam antibiotics, the level of 
resistance ranged between 37.25 to 41.17 %. 
The MIC results showed 88.23% resistance to 
cefotaxime, 83.35% to ceftriaxone, 82.35% to 
ceftazidime, 50.98% to ceftizoxime and 47.06% 
to ciprofloxacin. These values were much higher 
compared to the resistance patterns obtained by 
disc diffusion. However, when the numbers of 
resistant and intermediately resistant organisms 
were compiled, there was total agreement be-
tween the two phenotypic tests.  
Figure 2 shows the PCR amplification products 
of -lactamase genes. The results showed that 
22 isolates (43.14%) carried the blaSHV gene, 18 
(35.29%) had blaTEM and 16 (31.37%) harbored 
the blaCTX-M genes. The DDST results detected 
ESBL production in 14 isolates (27.45%) of 
which, 4 carried the blaSHV gene, 3 had blaCTX-M, 
3 harbored blaTEM, 1 carried blaSHV-TEM and sur-
prisingly 3 did not have any of the 3 genes 
tested. Of the 37 Organisms which did not pro-
duce ESBL, 9 lacked all 3 genes, 7 carried 
blaSHV, 4 blaCTX-M, 3 blaTEM, 4 blaSHV-TEM, 4 
blaSHV-CTX-M, 3 blaTEM-CTX-M and finally, 2 carried 
all 3. These results suggest that other types of 
ESBL may be responsible for the ESBL pheno-
type.
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Fig. 1: Antibiotic susceptibility of 51 urinary isolates of Klebsiella pneumoniae measured by disc diffu-
sion. AMX, amoxicillin, FM, nitrofurantoin, AN, amikacin, CAZ, ceftazidime, CRO, cefriaxone, CTX,  
cefotaxime, CT, ceftizoxime, CP, ciprofloxacin, GM, gentamicin 
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Fig. 2:  PCR amplification of -lactamase genes in 
urinary isolates of K. pneumoniae. M, 100 bp DNA 
ladder, C-, negative control, C+, positive control, 
lanes 1-2, blaCTX-M  (891 bp), lanes 3- 4, blaTEM  (850 
bp), lanes 5-6, blaSHV  (800 bp) amplification prod-
ucts 
 
Discussion 
 
Klebsiella pneumoniae has rapidly become the 
most common ESBL producing organism, mak-
ing its eradication difficult from high risk wards 
such as intensive care units. In our study, 
27.45% of the urinary isolates of K. pneumoniae 
were ESBL producers. Despite the fact that a 
small number of isolates were tested, ESBL 
production among our isolates was higher than a 
study performed in Semnan, Iran where ESBL 
production in urinary isolates was reported to be 
19.6% (17). On the other hand, our results 
showed a lower rate of ESBL production com-
pared to most of the other studies carried out in 
Iran and other parts of the Middle or Far East 
(11-18). The prevalence rates of ESBL produc-
tion are different in different countries or differ-
ent parts of each country and are very much de-
pendent upon antibiotic policies in every region.  
The conventional disc diffusion method does not 
usually allow for routine differentiation of 
ESBL producing strains. Several methods have 
been devised to differentiate between ESBL and 
non-ESBL producers among which, the double 
disc diffusion test has been reported to be the 
most discriminating (25-26). Also, molecular 
detection methods such as PCR have been used 
for molecular differentiation of β-lactamase pro-
ducing isolates. However, most of the studies 
performed, aim for the detection of the more 
commonly occurring β-lactamase genes such as 
the TEM and SHV family and it is not practical 
to screen for a large number of -lactamase 
genes. In a study carried out in Taiwan, a corre-
lation was reported between phenotypic resis-
tance to cefotaxime, ceftazidime and ceftriaxone 
in ESBL producing K. pneumoniae isolates and 
presence of blaSHV, blaCTX-M and blaVEB-1 like 
genes but not blaTEM (22). Our results showed no 
relation between presence of TEM, SHV and 
CTX-M -lactamase genes with -lactamase 
production or ESBL phenotype. Presence of 
ESBLs can be masked by the expression of 
chromosomal or plasmid mediated AmpC -
lactamases. Also, ESBL producing strains with 
AmpC -lactamases can cause a false negative 
in ESBL detection (25-27). More importantly, 
expression of -lactamase genes depend upon 
the environmental conditions such as the pres-
ence of antibiotics and gene presence shown by 
PCR does not necessarily indicate its expression.  
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